Toggle navigation
Home
Search
Services
Blog
Contact
About
Anti Tach H Therapy in Leukemia and Lymphoma
Junghans, Richard P.
Beth Israel Deaconess Medical Center, Boston, MA, United States
Search 40 grants from Richard Junghans
Search grants from Beth Israel Deaconess Medical Center
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Massachusetts Institute of Technology
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Longitudinal Genetic Analysis of Complex Traits
Pubertal hyperandrogenemia, modification of day-night GnRH secretion, and PCOS
Homeless Male Life Stabilization Study
Protein Interactions with 43kd
Update and Revise Macroeconomic Model
Recently added grants:
Anticancer peptide therapeutics
BLR&D Research Career Scientist Award Application
Enhancing Community Integration for Homeless Veterans
Functional and neurophysiological effects of a progressive robot assisted gait intervention early post stroke
Next generation in vivo miniature microscopes integrating dual-color imaging, 3D imaging, and optogenetic stimulation with a cloud-compatible data acquisition platform
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Small Research Grants (R03)
Project #
5R03CA067079-02
Application #
2110655
Study Section
Cancer Clinical Investigation Review Committee (CCI)
Project Start
1995-04-01
Project End
1997-03-31
Budget Start
1996-04-01
Budget End
1997-03-31
Support Year
2
Fiscal Year
1996
Total Cost
Indirect Cost
Institution
Name
Beth Israel Deaconess Medical Center
Department
Type
DUNS #
076593722
City
Boston
State
MA
Country
United States
Zip Code
02215
Related projects
NIH 1996
R03 CA
Anti Tach H Therapy in Leukemia and Lymphoma
Junghans, Richard P. / Beth Israel Deaconess Medical Center
NIH 1995
R03 CA
Anti Tach H Therapy in Leukemia and Lymphoma
Junghans, Richard P. / Beth Israel Deaconess Medical Center
Comments
Be the first to comment on Richard Junghans's grant